20
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Methadone dose and post-mortem blood concentration

&
Pages 329-333 | Published online: 12 Jul 2009

  • Drummer OH, Opeskin K, Syrjanen M, Cordner M. Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. Am J Forens Med Pathol 1992;13:346-50.
  • Williamson PA, Foreman KJ, White JM, Anderson G. Methadone-related overdose deaths in South Australia, 1984-1994. Med JAust 1997,166:302-5.
  • Caplehorn JRM. Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity. Drug Alcohol Rev 1998,17: 9-17.
  • Caplehorn JRM, Drummer OH. Mortality associated with NSW methadone programs in 1994: lives lost and saved. Med J Aust 1999,170:104-9.
  • Zador S, Sunjic S. Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995. Addiction 2000,95:77-84.
  • Caplehorn JRM, Dalton MSYN, Haldar F, Petrenas A-M, Nisbet JG. Methadone maintenance and addicts' risk of fatal heroin overdose. Substance Use Misuse 1996,31: 177-96.
  • Barren DH, Luk AJ, Parrish RG, Jones TS. An investigation of medical examiner cases in which methadone was detected, Harris County, Texas, 1987-1992. J Forens Sci 1996; 41:442-8.
  • Green H, James RA, Gilbert JD, Harpas P, Byard RW. Methadone maintenance programs--a two-edged sword? Am J Forens Med Path 2000;21:359-61.
  • Cooper GAA, Seymour A, Cassidy MT, Oliver JS. A study of methadone fatalities in the Strathclyde region, 1991-1996. Med Sci Law 1999;39:233-42.
  • Clark JC, Milroy CM, Forrest ARW. Deaths from methadone use. J Clin Forens Med 1995;2:143-4.
  • Servais D, Erkens M. Methadone-related deaths in the area of Aachen, Germany (1994-1998). Rechtsmedizin 2000; 10:65-70.
  • Teichtahl H, Prodromidis A, Miller B, Cherry G, Kronborg I. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 2001;96: 395-403.
  • Verebely K, Volavka J, Mule S, Resnick R. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther 1975;18:180-90.
  • Eap CB, Bertschy G, Baumann P, Finkbeiner T, Gastpar M, Scherbaum N. High interindividual variability of methadone enantiomer blood levels to dose ratios [Letter]. Arch Gen Psychiatry 1998;55:89-90.
  • Drummer OH, Syrjanen M, Opeskin K, Cordner SM. Deaths of heroin addicts starting on a methadone maintenance programme. Lancet 1990;i:108.
  • Caplehorn JRM, Drummer OH. Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines. Aust NZ J Public Health: 2002;26:358-62.
  • Wolff K, SandersonM, Hay AWM, Ralstrick D. Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 1991;37:205-9.
  • Pounder DJ, Jones GR. Post-mortem drug redistribution--a toxicological nightmare. Forens Sci lnt 1990;45:253-63.
  • Moriya F, Hashimoto Y. Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. J Forens Sci 1999;44:10-16.
  • Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forens Sci 1990;35:243-70.
  • Cook DS, Braithwaite KA. Estimating antemortem drug concentrations from postmortem samples: the influence of postmortem redistribution. J Clin Pathol 2000;53:282-5.
  • Milroy CM, Forrest ARW. Methadone deaths: a toxicological analysis. J Clin Pathol 2000;53:277-81.
  • Levine B, Dixon A, Smialek JE. Site dependence of postmortem blood methadone concentrations. Am J Forens Med Pathol 1995;16:97-100.
  • Gebski V, Leung O, McNeil D, Lunn D. SPIDA User's Manual, version 6. Sydney: Statistical Computing Laboratory, 1992.
  • Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research, 4th edn. Oxford: Blackwell Publishing Ltd, 2002.
  • Shapiro SS, WiIk MB. An analysis of variance test for normality: complete samples. Biometrika 1965;52: 591-611.
  • Kleinbaum DG. logistic regression: a self-learning text. New York: Springer-Verlag, 1994.
  • Horns WH, Rado M, Goldstein A. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride. Clin Pharmacol Ther 1975; 17:636-49.
  • Kreek MJ. Consequences associated with the use of methadone. In: Cooper JR, Altman F, Brown BS, Czechowicz D. (eds) Research in the treatment of narcotic addiction: state of the art. Rockville, MD: National Institute on Drug Abuse, 1983:467-82.
  • Benet LZ, Øie S, Schwartz JB. Design and optimization of dosage regimens; pharmacokinetic data. In: Hardman JG, Limbird LE. (eds) Goodman & Oilman's The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill, 1996:1758.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.